1 year return (CAGR)
508.04%
Oruka Therapeutics, Inc. Exchange (NASDAQ, USD)
ORKA
84.46
+1.17 (+1.25%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
56.64%
5 year return (CAGR)
21.71%
10 year return (CAGR)
-17.62%
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
6.26B
Price/Sales
-
Ent value
6.02B
Price/Book
5.62
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
2.26%
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 93.38 |
| Daily high | 96.78 |
| Daily low | 91.53 |
| Daily Volume | 1.05M |
| All-time high | 1000024.70 |
| 1y analyst estimate | 155.00 |
| Beta | -0.16 |
| EPS (TTM) | -2.11 |
| Dividend per share | 0.00 |
| Ex-div date | 29 Aug 2024 |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| ORKA | S&P500 | |
| Current price drop from All-time high | -99.99% | -0.84% |
| Highest price drop | -100.00% | -56.47% |
| Date of highest drop | 10 Apr 2025 | 9 Mar 2009 |
| Avg drop from high | -66.18% | -10.68% |
| Avg time to new high | 5 days | 12 days |
| Max time to new high | 7324 days | 1805 days |
News
